Interstitial lung disease clinic. Hospital María Ferrer Buenos Aires, Argentina.
Interstitial lung disease clinic. Hospital María Ferrer Buenos Aires, Argentina.
Pulmonology. 2020 Jan-Feb;26(1):3-9. doi: 10.1016/j.pulmoe.2019.08.007. Epub 2019 Nov 14.
Chronic hypersensitivity pneumonitis (CHP) is an interstitial lung disease with limited treatment response and bad prognosis. Sometimes it is indistinguishable from idiopathic pulmonary fibrosis (IPF) becoming one of the main differential diagnosis. The aim of our study is to compare survival and functional decline between these two entities.
Survival and functional decline more than 10% in FVC were compared using Kaplan Meier (KM) method between patients with CHP and IPF. Cox proportional hazard analysis was used to identify independent predictors of survival and functional decline.
146 patients were included, 54 with CHP and 92 with IPF. KM rate for 2 years survival was 0.71 (CI 95% 0,6-0,8) for CHP group and 0,83 (CI 95% 0,66 - 0,92) for IPF (p=0,027). Nevertheless this difference disappeared using Cox proportional hazard analysis, the adjusted HR for survival among CHP patients was 0,53 (CI 95% 0,25-1,15) (p=0,11). There was no difference in functional evolution between the two groups. KM rate for a decline more than or equal to 10% was 0,64 for CHP (CI 95% 0,43-0,79) and 0,78 for IPF (IC 95% 0,6-0,88) (p=0,22). This observation did not change after using Cox proportional hazard analysis.
Our study shows that both IPF and CHP are fibrosing interstitial diseases with a similar evolution and survival. It might be possible that therapeutic approach in patients with CHP should change in the light of these observations.
慢性过敏性肺炎(CHP)是一种间质性肺疾病,治疗反应有限,预后不良。有时它与特发性肺纤维化(IPF)无法区分,成为主要鉴别诊断之一。我们研究的目的是比较这两种疾病的生存和功能下降情况。
使用 Kaplan-Meier(KM)方法比较 CHP 和 IPF 患者的生存和 FVC 下降超过 10%的情况。使用 Cox 比例风险分析确定生存和功能下降的独立预测因素。
共纳入 146 例患者,其中 CHP 54 例,IPF92 例。CHP 组 2 年生存率为 0.71(95%CI 0.6-0.8),IPF 组为 0.83(95%CI 0.66-0.92)(p=0.027)。然而,使用 Cox 比例风险分析后,这种差异消失了,CHP 患者的生存调整 HR 为 0.53(95%CI 0.25-1.15)(p=0.11)。两组患者的功能变化无差异。CHP 组下降超过或等于 10%的 KM 率为 0.64(95%CI 0.43-0.79),IPF 组为 0.78(95%CI 0.6-0.88)(p=0.22)。使用 Cox 比例风险分析后,这一观察结果没有改变。
我们的研究表明,IPF 和 CHP 都是纤维化的间质性疾病,具有相似的演变和生存。根据这些观察结果,CHP 患者的治疗方法可能需要改变。